| |
| |
|
| Insider
Information: |
Kumar Ramesh |
| Relationship: |
Director |
| City: |
Newtown |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
102,227 |
|
|
Indirect Shares
|
150,037 |
|
|
| Direct
Value |
$74,626 |
|
|
|
Indirect Value
|
$109,527 |
|
|
| Total
Shares |
252,264 |
|
|
| Total
Value |
$184,153 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onconova Therapeutics, Inc. |
ONTX |
President and CEO, Dir... |
2017-04-26 |
102,227 |
2013-07-24 |
150,037 |
Premium* |
|
|
Ocugen Ord Shs |
OCGN |
Director |
2022-10-06 |
0 |
2021-04-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2022-10-06 |
4 |
AS |
$1.83 |
$8,235 |
D/D |
(4,500) |
0 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2022-10-06 |
4 |
OE |
$0.51 |
$2,295 |
D/D |
4,500 |
4,500 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2022-07-18 |
4 |
AS |
$2.57 |
$19,275 |
D/D |
(7,500) |
0 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2022-07-18 |
4 |
OE |
$0.51 |
$3,825 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2022-04-18 |
4 |
AS |
$2.83 |
$21,225 |
D/D |
(7,500) |
0 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2022-04-18 |
4 |
OE |
$0.51 |
$3,825 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2022-01-18 |
4 |
OE |
$0.51 |
$3,825 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2022-01-18 |
4 |
AS |
$4.07 |
$30,525 |
D/D |
(7,500) |
0 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2021-10-18 |
4 |
AS |
$8.13 |
$60,975 |
D/D |
(7,500) |
0 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2021-10-18 |
4 |
OE |
$0.51 |
$3,825 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2021-07-19 |
4 |
AS |
$6.40 |
$48,000 |
D/D |
(7,500) |
0 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2021-07-19 |
4 |
OE |
$0.51 |
$3,825 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2021-04-19 |
4 |
AS |
$5.33 |
$39,975 |
D/D |
(7,500) |
0 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2021-04-19 |
4 |
OE |
$0.51 |
$3,825 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
President and CEO |
• • – |
2017-04-26 |
4 |
B |
$2.10 |
$50,001 |
D/D |
23,810 |
102,227 |
2.81 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
President and CEO |
• • – |
2016-07-29 |
4 |
OE |
$4.10 |
$208,136 |
D/D |
50,765 |
78,417 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
President and CEO |
• • – |
2014-02-10 |
4 |
AS |
$15.11 |
$302,200 |
D/D |
(20,000) |
276,500 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
President and CEO |
• • – |
2014-02-10 |
4 |
OE |
$6.00 |
$120,000 |
D/D |
20,000 |
296,500 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
President and CEO |
• • – |
2014-02-07 |
4 |
OE |
$6.00 |
$81,258 |
D/D |
13,543 |
290,043 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
President and CEO |
• • – |
2014-02-03 |
4 |
AS |
$15.07 |
$301,400 |
D/D |
(20,000) |
276,500 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
President and CEO |
• • – |
2014-02-03 |
4 |
OE |
$6.00 |
$120,000 |
D/D |
20,000 |
296,500 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
President and CEO |
• • – |
2014-01-31 |
4 |
OE |
$6.00 |
$120,000 |
D/D |
20,000 |
296,500 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
President and CEO |
• • – |
2014-01-31 |
4 |
AS |
$15.03 |
$300,600 |
D/D |
(20,000) |
276,500 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
President and CEO |
• • – |
2014-01-30 |
4 |
AS |
$15.05 |
$301,000 |
D/D |
(20,000) |
276,500 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
President and CEO |
• • – |
2014-01-30 |
4 |
OE |
$2.67 |
$102,498 |
D/D |
20,000 |
296,500 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
